Randomized phase III study of paclitaxel plus carboplatin with or without sorafenib as second-line treatment in patients with advanced melanoma

被引：0
|
作者：
Agarwala, S. S.
Keilholz, U.
Hogg, D.
Robert, C.
Hersey, P.
Eggermont, A.
Grabbe, S.
Gonzalez, R.
Patel, K.
Hauschild, A.
机构：
[1] St Lukes Hosp & Hlth Network, Bethlehem, PA USA
[2] Charite, Berlin, Germany
[3] Univ Toronto, Toronto, ON, Canada
[4] Inst Gustave Roussy, Villejuif, France
[5] Newcastle Mater Misericordiae Hosp, Newcastle, NSW, Australia
[6] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[7] Univ Klinikum Essen, Essen, Germany
[8] Univ Colorado, Ctr Canc, Aurora, CO USA
[9] Onyx Pharmaceut, Emeryville, CA USA
[10] Univ Kiel, Kiel, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8510
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A phase II study of paclitaxel (P) and carboplatin (C) as second-line treatment in patients (PTS) with small-cell lung cancer (SCLC)
    Agelaki, S
    Agelidou, M
    Blazogiannakis, G
    Tsiafaki, X
    Palamidas, T
    Kouroussis, C
    Kakolyris, S
    Malliotakis, C
    Samonis, G
    Georgoulias, V
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S258 - S259
  • [42] Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: A phase III randomized trial
    Kosmidis, P
    Mylonakis, N
    Nicolaides, C
    Kalophonos, C
    Samantas, E
    Boukovinas, J
    Fountzilas, G
    Skarlos, D
    Economopoulos, T
    Tsavdaridis, D
    Papakostas, P
    Bacoyiannis, C
    Dimopoulos, M
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) : 3578 - 3585
  • [43] Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric cancer who previously treated with first-line nivolumab plus chemotherapy
    Jeon, Youngkyung
    Jeong, Sun Young
    Jang, Jaeyeon
    Jung, Ye Ji
    Choi, Daeho
    Hong, Joohyun
    Kim, Seung Tae
    Kang, Won Ki
    Lee, Jeeyun
    CANCER RESEARCH, 2023, 83 (07)
  • [44] A randomized phase III study of carboplatin plus nab-paclitaxel with or without nintedanib for NSCLC with IPF (J-SONIC)
    Otsubo, K.
    Kishimoto, J.
    Kenmotsu, H.
    Minegishi, Y.
    Horinouchi, H.
    Kato, T.
    Ichihara, E.
    Shiraki, A.
    Atagi, S.
    Ando, M.
    Yamamoto, N.
    Okamoto, I.
    ANNALS OF ONCOLOGY, 2019, 30
  • [45] Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)
    Javle, M. M.
    Oh, D-Y
    Ikeda, M.
    Yong, W-P
    Hsu, K.
    Lindmark, B.
    McIntyre, N.
    Firth, C.
    ESMO OPEN, 2022, 7 (01)
  • [46] Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non Small-Cell Lung Cancer
    Scagliotti, Giorgio
    Novello, Silvia
    von Pawel, Joachim
    Reck, Martin
    Pereira, Jose Rodrigues
    Thomas, Michael
    Abrao Miziara, Jose Elias
    Balint, Beatrix
    De Marinis, Filippo
    Keller, Alan
    Aren, Osvaldo
    Csollak, Maria
    Albert, Istvan
    Henrique Barrios, Carlos
    Grossi, Francesco
    Krzakowski, Maciej
    Cupit, Lisa
    Cihon, Frank
    DiMatteo, Sandra
    Hanna, Nasser
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) : 1835 - 1842
  • [47] Ramucirumab plus paclitaxel as a second-line treatment for advanced gastric or gastro-oesophageal junction cancer
    Nature Reviews Gastroenterology & Hepatology, 2014, 11 (11) : 642 - 642
  • [48] A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer
    Treat, J. A.
    Gonin, R.
    Socinski, M. A.
    Edelman, M. J.
    Catalano, R. B.
    Marinucci, D. M.
    Ansari, R.
    Gillenwater, H. H.
    Rowland, K. M.
    Comis, R. L.
    Obasaju, C. K.
    Belani, C. P.
    ANNALS OF ONCOLOGY, 2010, 21 (03) : 540 - 547
  • [49] Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: Preliminary results of a phase I study
    Lhomme, C
    Kerbrat, P
    Lejeune, C
    Guastalla, JP
    Fumoleau, P
    Goupil, A
    Heron, JF
    Cassin, MA
    Pruvot, I
    Soares, JA
    Chazard, M
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 48 - 54
  • [50] A RETROSPECTIVE STUDY OF WEEKLY PACLITAXEL AS SECOND-LINE TREATMENT FOR ADVANCED OR RECURRENT ESOPHAGEAL CANCER
    Sakamoto, Takeshi
    Takegawa, Naoki
    Kushida, Saeko
    Tsumura, Hidetaka
    Mimura, Takuya
    Tobimatsu, Kazutoshi
    Yamamoto, Nobuyoshi
    Miki, Ikuya
    Tsuda, Masahiro
    Inokuchi, Hideto
    ANNALS OF ONCOLOGY, 2014, 25
12345